One of the defining characteristics of solid tumors is the scheme of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial probe team, led by trust from the Siteman Center of Cancer Nanotechnology Excellence, has full-fledged a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.

More: - Read the rest here